Article 23 Oct 2023 The Latest Episode Of The LDT Drama: FDA Issues Long-Awaited Proposed Rule For Laboratory Developed Tests United States Healthcare
Article 03 Dec 2020 Marketers Beware: As COVID-19 Cases Increase, FDA, FTC Increase Efforts To Crack Down On Fraudulent And Deceptive Marketing And Sales Of Purported ‘Virus Cures' United States Coronavirus
Article 15 Jan 2020 FDA's Section 804 Prescription Drug Importation Program And 801(d)(1)(B) Guidance United States Healthcare
Article 12 Nov 2018 FDA Revamps Cybersecurity Guidance For Marketed Medical Devices United States Technology
Article 08 Feb 2018 No (Expensive) Lunch For You! New NJ Regulation Caps Payments To Doctors United States Healthcare
Article 24 Jan 2018 House Panel Approves Off-Label Communication, OTC Monograph User Fee, Good Samaritan Health Professionals Bills United States Healthcare
Article 25 Oct 2017 FDA Sets the Stage for Cures Act Breakthrough Devices Program in Highly Anticipated Guidance Document United States Healthcare
Article 19 Jan 2017 FDA Advances LDT Dialogue With New Discussion Paper Containing Updated CMS/FDA Oversight Proposal United States Healthcare